Mon. 18 Mar 2024, 4:15pm ET
Benzinga
Earnings, News
Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(0.98) per share which missed the analyst consensus estimate of $(0.10) by 880 percent. This is a 20.33 percent increase over losses of $(1.23) per share from the same period last year.